However, results vary depending on individual skin types, natural pigmentation, and the dosage or frequency of treatments
This has significant implications on the risk profile of GLP-1 agonists in the perioperative setting
If you are tolerating once-weekly dosing well If your current schedule works, do not fix what is not broken
10.1016/j.isci.2020.101449 19 ChenQ.TesmerJ
Results The gut microbiota affects locomotion via GLP-1 signaling Animals displayed altered locomotion when their gut microbiome was depleted 13,14,15,16 , suggesting that locomotion is associated with the status of bacterial colonization, specific bacteria, and their metabolites 13,14,15,16
The protective effects varied depending on which drug researchers compared semaglutide against